Related Experiment Video
Updated: Sep 9, 2025

08:14
Comprehensive Analysis of Transcription Dynamics from Brain Samples Following Behavioral Experience
Published on: August 26, 2014
11.8K
Deciphering transcriptomic changes in chemobrain: a comprehensive review
Tusar Kanta Acharya1, Yuan Pan1,2,3, Peter M Grace1,3
1Laboratories of Neuroimmunology, Department of Symptom Research, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Acta Neuropathologica Communications
|August 30, 2025
Summary
Chemotherapy-induced cognitive impairments (CICI) affect cancer survivors
Area of Science:
- Neuroscience
- Oncology
- Genomics
Background:
- Chemotherapy-induced cognitive impairments (CICI), or "chemobrain," are a significant side effect for cancer survivors.
- These impairments affect memory, multitasking, and overall quality of life.
Purpose of the Study:
- To review the molecular mechanisms of CICI, focusing on transcriptomic data.
- To understand the link between chemotherapy agents and cognitive dysfunction.
Main Methods:
- RNA sequencing
- cDNA microarrays
- Single-cell transcriptomics
- Spatial transcriptomics
Main Results:
- Transcriptomic analyses reveal altered gene expression profiles in CICI.
- Key implicated mechanisms include blood-brain barrier disruption, neuroinflammation, and oxidative stress.
- Specific chemotherapy agents like doxorubicin, cisplatin, and paclitaxel are associated with CICI.
Conclusions:
- Transcriptomics offers crucial insights into CICI pathophysiology.
- Developing single-cell atlases and spatial transcriptomics can reveal cellular heterogeneity and gene expression dynamics.
- Integrating transcriptomic findings with clinical data is vital for personalized interventions to improve survivors' cognitive health.
More Related Videos
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
366
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
366

